Home LiteratureArticle Details
PMID: 16820530 Published · epublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Metabolic regulation of apoB mRNA editing is associated with phosphorylation of APOBEC-1 complementation factor.

Nucleic acids research ·Vol. 34 ·No. 11 ·2006-00-00 ·Pages 3299-308

Lehmann DM, Galloway CA, Sowden MP, Smith HC

Abstract

Apolipoprotein B (apoB) mRNA editing is a nuclear event that minimally requires the RNA substrate, APOBEC-1 and APOBEC-1 Complementation Factor (ACF). The co-localization of these macro-molecules within the nucleus and the modulation of hepatic apoB mRNA editing activity have been described following a variety of metabolic perturbations, but the mechanism that regulates editosome assembly is unknown. APOBEC-1 was effectively co-immunoprecipitated with ACF from nuclear, but not cytoplasmic extracts. Moreover, alkaline phosphatase treatment of nuclear extracts reduced the amount of APOBEC-1 co-immunoprecipitated with ACF and inhibited in vitro editing activity. Ethanol stimulated apoB mRNA editing was associated with a 2- to 3-fold increase in ACF phosphorylation relative to that in control primary hepatocytes. Significantly, phosphorylated ACF was restricted to nuclear extracts where it co-sedimented with 27S editing competent complexes. Two-dimensional phosphoamino acid analysis of ACF immunopurified from hepatocyte nuclear extracts demonstrated phosphorylation of serine residues that was increased by ethanol treatment. Inhibition of protein phosphatase I, but not PPIIA or IIB, stimulated apoB mRNA editing activity coincident with enhanced ACF phosphorylation in vivo. These data demonstrate that ACF is a metabolically regulated phosphoprotein and suggest that this post-translational modification increases hepatic apoB mRNA editing activity by enhancing ACF nuclear localization/retention, facilitating the interaction of ACF with APOBEC-1 and thereby increasing the probability of editosome assembly and activity.

MeSH Terms
APOBEC-1 Deaminase Animals Apolipoproteins B/genetics,metabolism Cell Line Cell Nucleus/chemistry,enzymology Cells, Cultured Cytidine Deaminase/isolation & purification Enzyme Inhibitors/pharmacology Heterogeneous-Nuclear Ribonucleoproteins/isolation & purification,metabolism Liver/metabolism Male Phosphoprotein Phosphatases/antagonists & inhibitors Phosphoproteins/isolation & purification,metabolism Phosphorylation RNA Editing/drug effects RNA, Messenger/metabolism Rats Rats, Sprague-Dawley
Chemicals
APOBEC-1 complementation factor, rat Apolipoproteins B Enzyme Inhibitors Heterogeneous-Nuclear Ribonucleoproteins Phosphoproteins RNA, Messenger Phosphoprotein Phosphatases APOBEC-1 Deaminase Apobec1 protein, rat Cytidine Deaminase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Lehmann David M
Department of Toxicology, University of Rochester, Rochester, NY 14642, USA.
Galloway Chad A
Sowden Mark P
Smith Harold C
References (55)
55 references, click to expand
  1. Molecular cloning of apobec-1 complementation factor, a novel RNA-binding protein involved in the editing of apolipoprotein B mRNA.
    Mol Cell Biol. 2000 Mar;20(5):1846-54 PMID: 10669759
  2. Apolipoprotein B mRNA editing is an intranuclear event that occurs posttranscriptionally coincident with splicing and polyadenylation.
    J Biol Chem. 1991 Oct 25;266(30):20550-4 PMID: 1939106
  3. Induction of cytidine to uridine editing on cytoplasmic apolipoprotein B mRNA by overexpressing APOBEC-1.
    J Biol Chem. 2000 Jul 28;275(30):22663-9 PMID: 10833526
  4. Calcium increases apolipoprotein B mRNA editing.
    Biochem Biophys Res Commun. 2000 Oct 14;277(1):221-7 PMID: 11027667
  5. Two-dimensional phosphoamino acid analysis.
    Methods Mol Biol. 2001;124:49-65 PMID: 11100467
  6. Intracellular trafficking determinants in APOBEC-1, the catalytic subunit for cytidine to uridine editing of apolipoprotein B mRNA.
    Exp Cell Res. 2001 Jul 15;267(2):153-64 PMID: 11426934
  7. Phosphorylation is a regulatory mechanism in apolipoprotein B mRNA editing.
    Biochem J. 2001 Aug 1;357(Pt 3):661-72 PMID: 11463337
  8. Commitment of apolipoprotein B RNA to the splicing pathway regulates cytidine-to-uridine editing-site utilization.
    Biochem J. 2001 Nov 1;359(Pt 3):697-705 PMID: 11672445
  9. Mutagenesis of apobec-1 complementation factor reveals distinct domains that modulate RNA binding, protein-protein interaction with apobec-1, and complementation of C to U RNA-editing activity.
    J Biol Chem. 2001 Dec 7;276(49):46386-93 PMID: 11571303
  10. Ethanol stimulates apolipoprotein B mRNA editing in the absence of de novo RNA or protein synthesis.
    Biochem Biophys Res Commun. 2001 Dec 21;289(5):1162-7 PMID: 11741314
  11. The editosome for cytidine to uridine mRNA editing has a native complexity of 27S: identification of intracellular domains containing active and inactive editing factors.
    J Cell Sci. 2002 Mar 1;115(Pt 5):1027-39 PMID: 11870221
  12. Identification of domains in apobec-1 complementation factor required for RNA binding and apolipoprotein-B mRNA editing.
    RNA. 2002 Jan;8(1):69-82 PMID: 11871661
  13. Two proteins essential for apolipoprotein B mRNA editing are expressed from a single gene through alternative splicing.
    J Biol Chem. 2002 Apr 12;277(15):12703-9 PMID: 11815617
  14. Thyroid hormone regulates hepatic triglyceride mobilization and apolipoprotein B messenger ribonucleic Acid editing in a murine model of congenital hypothyroidism.
    Endocrinology. 2003 Feb;144(2):711-9 PMID: 12538634
  15. Messenger RNA editing in mammals: new members of the APOBEC family seeking roles in the family business.
    Trends Genet. 2003 Apr;19(4):207-16 PMID: 12683974
  16. The apolipoprotein B mRNA editing complex performs a multifunctional cycle and suppresses nonsense-mediated decay.
    EMBO J. 2003 Aug 1;22(15):3971-82 PMID: 12881431
  17. A novel nuclear localization signal in the auxiliary domain of apobec-1 complementation factor regulates nucleocytoplasmic import and shuttling.
    J Biol Chem. 2003 Oct 17;278(42):41198-204 PMID: 12896982
  18. Use of okadaic acid to inhibit protein phosphatases in intact cells.
    Methods Enzymol. 1991;201:469-76 PMID: 1658560
  19. Specific inhibition of calcineurin by type II synthetic pyrethroid insecticides.
    Biochem Pharmacol. 1992 Apr 15;43(8):1777-84 PMID: 1315545
  20. The isolation of novel inhibitory polypeptides of protein phosphatase 1 from bovine thymus nuclei.
    J Biol Chem. 1992 Aug 15;267(23):16538-44 PMID: 1322907
  21. Three distinct RNA sequence elements are required for efficient apolipoprotein B (apoB) RNA editing in vitro.
    Nucleic Acids Res. 1992 Nov 25;20(22):6007-14 PMID: 1461733
  22. Apolipoprotein B messenger RNA editing in rat liver: developmental and hormonal modulation is divergent from apolipoprotein A-IV gene expression despite increased hepatic lipogenesis.
    J Lipid Res. 1992 Dec;33(12):1843-56 PMID: 1479293
  23. Extract-specific heterogeneity in high-order complexes containing apolipoprotein B mRNA editing activity and RNA-binding proteins.
    J Biol Chem. 1993 Apr 5;268(10):7382-92 PMID: 8463271
  24. On target with a new mechanism for the regulation of protein phosphorylation.
    Trends Biochem Sci. 1993 May;18(5):172-7 PMID: 8392229
  25. Cantharidin, another natural toxin that inhibits the activity of serine/threonine protein phosphatases types 1 and 2A.
    FEBS Lett. 1993 Sep 20;330(3):283-6 PMID: 8397101
  26. Apolipoprotein B mRNA editing in 12 different mammalian species: hepatic expression is reflected in low concentrations of apoB-containing plasma lipoproteins.
    J Lipid Res. 1993 Aug;34(8):1367-83 PMID: 8409768
  27. Protein phosphatase 2A and its [3H]cantharidin/[3H]endothall thioanhydride binding site. Inhibitor specificity of cantharidin and ATP analogues.
    Biochem Pharmacol. 1993 Oct 19;46(8):1435-43 PMID: 8240393
  28. Tissue-specific, developmental and nutritional regulation of the gene encoding the catalytic subunit of the rat apolipoprotein B mRNA editing enzyme: functional role in the modulation of apoB mRNA editing.
    J Lipid Res. 1995 Mar;36(3):414-28 PMID: 7775854
  29. Serine/threonine protein phosphatases.
    Biochem J. 1995 Oct 1;311 ( Pt 1):17-29 PMID: 7575450
  30. Ethanol modulates apolipoprotein B mRNA editing in the rat.
    J Lipid Res. 1995 Oct;36(10):2069-78 PMID: 8576634
  31. Determinants involved in regulating the proportion of edited apolipoprotein B RNAs.
    RNA. 1996 Mar;2(3):274-88 PMID: 8608451
  32. Regulation of hepatic apolipoprotein B RNA editing in the genetically obese Zucker rat.
    Metabolism. 1996 Sep;45(9):1056-8 PMID: 8781289
  33. Tissue-specific inhibition of apolipoprotein B mRNA editing in the liver by adenovirus-mediated transfer of a dominant negative mutant APOBEC-1 leads to increased low density lipoprotein in mice.
    J Biol Chem. 1997 Jan 17;272(3):1456-60 PMID: 8999814
  34. A guide to RNA editing.
    RNA. 1997 Oct;3(10):1105-23 PMID: 9326486
  35. Partial characterization of the auxiliary factors involved in apolipoprotein B mRNA editing through APOBEC-1 affinity chromatography.
    J Biol Chem. 1997 Oct 31;272(44):27700-6 PMID: 9346911
  36. Multiple protein domains determine the cell type-specific nuclear distribution of the catalytic subunit required for apolipoprotein B mRNA editing.
    Proc Natl Acad Sci U S A. 1997 Nov 25;94(24):13075-80 PMID: 9371802
  37. Escherichia coli cytidine deaminase provides a molecular model for ApoB RNA editing and a mechanism for RNA substrate recognition.
    J Mol Biol. 1998 Jan 30;275(4):695-714 PMID: 9466941
  38. Analysis of protein complexes assembled on apolipoprotein B mRNA for mooring sequence-dependent RNA editing.
    Methods. 1998 May;15(1):27-39 PMID: 9614650
  39. Insulin increases expression of apobec-1, the catalytic subunit of the apolipoprotein B mRNA editing complex in rat hepatocytes.
    Metabolism. 1998 Jul;47(7):869-73 PMID: 9667237
  40. A sequence-specific RNA-binding protein complements apobec-1 To edit apolipoprotein B mRNA.
    Mol Cell Biol. 1998 Aug;18(8):4426-32 PMID: 9671452
  41. Ethanol increases apolipoprotein B mRNA editing in rat primary hepatocytes and McArdle cells.
    Biochem Biophys Res Commun. 1998 Nov 18;252(2):334-9 PMID: 9826530
  42. NMR structure of the apoB mRNA stem-loop and its interaction with the C to U editing APOBEC1 complementary factor.
    RNA. 2005 Feb;11(2):173-86 PMID: 15659357
  43. The tyrosine kinases Fyn and Hck favor the recruitment of tyrosine-phosphorylated APOBEC3G into vif-defective HIV-1 particles.
    Biochem Biophys Res Commun. 2005 Apr 15;329(3):917-24 PMID: 15752743
  44. Identification of novel alternative splice variants of APOBEC-1 complementation factor with different capacities to support apolipoprotein B mRNA editing.
    J Biol Chem. 2004 Jan 2;279(1):197-206 PMID: 14570923
  45. The structure of a yeast RNA-editing deaminase provides insight into the fold and function of activation-induced deaminase and APOBEC-1.
    Proc Natl Acad Sci U S A. 2004 May 25;101(21):8114-9 PMID: 15148397
  46. Optimization of apolipoprotein B mRNA editing by APOBEC1 apoenzyme and the role of its auxiliary factor, ACF.
    RNA. 2004 Sep;10(9):1399-411 PMID: 15273326
  47. Replication protein A interacts with AID to promote deamination of somatic hypermutation targets.
    Nature. 2004 Aug 26;430(7003):992-8 PMID: 15273694
  48. High resolution two-dimensional electrophoresis of proteins.
    J Biol Chem. 1975 May 25;250(10):4007-21 PMID: 236308
  49. Identification of high levels of protein phosphatase-1 in rat liver nuclei.
    FEBS Lett. 1986 Jul 28;203(2):197-202 PMID: 3015674
  50. A novel form of tissue-specific RNA processing produces apolipoprotein-B48 in intestine.
    Cell. 1987 Sep 11;50(6):831-40 PMID: 3621347
  51. Apolipoprotein B-48 is the product of a messenger RNA with an organ-specific in-frame stop codon.
    Science. 1987 Oct 16;238(4825):363-6 PMID: 3659919
  52. In vitro apolipoprotein B mRNA editing: identification of a 27S editing complex.
    Proc Natl Acad Sci U S A. 1991 Feb 15;88(4):1489-93 PMID: 1996349
  53. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes.
    Cell. 1991 Aug 23;66(4):807-15 PMID: 1715244
  54. Sequence requirements for the editing of apolipoprotein B mRNA.
    J Biol Chem. 1991 Sep 5;266(25):16301-4 PMID: 1885564
  55. Purification and molecular cloning of a novel essential component of the apolipoprotein B mRNA editing enzyme-complex.
    J Biol Chem. 2000 Jun 30;275(26):19848-56 PMID: 10781591
Article Info
Journal
Nucleic acids research
Abbr.
Nucleic Acids Res
ISSN
1362-4962
Published
2006-00-00
Epub
2006-00-04
Pages
3299-308
Language
English
Region
England
NLM ID
0411011
PMCID
PMC1500872
Subset
IM
Grants
NIDDK NIH HHS · R01 DK043739 · United States
NIEHS NIH HHS · T32 ES007026 · United States
NIEHS NIH HHS · 5T32 ES07026 · United States
NIDDK NIH HHS · DK43739 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com